Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus.
Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.
The mechanism of action of estramustine.
Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.
Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype.
Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. Br J Cancer. 1991 Aug; 64(2):267-73.
View in:
PubMed
subject areas
Anti-Bacterial Agents
Cell Cycle
Drug Resistance
Estramustine
Flow Cytometry
Humans
Male
Mutagenesis
Prostatic Neoplasms
Tumor Cells, Cultured
authors with profiles
Kenneth D. Tew